ATXN1 Polyclonal Antibody

Dodavatel: Reddot Biotech USA Inc.
Teplota skladování: Store at -20°C. Avoid freeze / thaw cycles.
Katalogové číslo:
RD75619A/20
20μL
2 821,00 Kč
NA OBJEDNÁNÍ
RD75619A/60
60μL
5 526,00 Kč
NA OBJEDNÁNÍ
RD75619A/120
120μL
9 274,00 Kč
NA OBJEDNÁNÍ
RD75619A/200
200μL
15 417,00 Kč
NA OBJEDNÁNÍ
Velikost balení:
Cena bez DPH:
Dostupnost:
Vložit do košíku
Zobrazovat ceny: bez DPH / včetně DPH
This is a ATXN1 Polyclonal Antibody from Reddot Biotech. This product is for Research Use Only.
The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA types I-III. ADCAI is genetically heterogeneous, with five genetic loci, designated spinocerebellar ataxia (SCA) 1, 2, 3, 4 and 6, being assigned to five different chromosomes. ADCAII, which always presents with retinal degeneration (SCA7), and ADCAIII often referred to as the `pure' cerebellar syndrome (SCA5), are most likely homogeneous disorders. Several SCA genes have been cloned and shown to contain CAG repeats in their coding regions.
ClonalityPolyclonal
Purification MethodAffinity purification
IsotypeIgG
HostRabbit
ImmunogenRecombinant protein of human ATXN1
SwissprotP54253
Gene AccessionBC117125
ReactivityHuman,Mouse,Rat
ApplicationsIHC,ELISA
ConjugationUnconjugated
DilutionIHC 1:50-1:200
Concentration0.4 mg/mL
BufferPBS with 0.05% sodium azide and 50% glycerol, PH7.4
0
RD75619A/120